Article: Clobetasol Propionate Foam Reduced Scalp Psoriasis.

Dr. Stein also compared the bioavailability of a super high-potency topical steroid, clobetasol propionate, in a foam delivery system.

The randomized, double-blind study involved 188 patients at 12 centers, all of whom had moderate to severe scalp psoriasis. Both the clobetasol propionate 0.05% foam and the 0.05% solution worked significantly better than a placebo in reducing erythema, scaling, plaque thickness, and pruritus.

The foam was markedly better than the solution at reducing scaling. It performed slightly better than the solution at reducing plaque ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!